Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMountview Est. Regulatory News (MTVW)

Share Price Information for Mountview Est. (MTVW)

Share Price is delayed by 15 minutes
Get Live Data
9,000.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 200.00 (2.273%)
Market Cap: £350.91m
MTVW Live PriceLast checked at - London Stock Exchange

Intraday Mountview Est. Share Chart

Interim Results

30 Nov 2011 10:24

RNS Number : 0460T
Mountview Estates PLC
30 November 2011
 



Chairman's Statement

 

On the following pages are the unaudited Accounts for the six months ended 30 September 2011. Revenue is down by 12.5% but earnings per share are down by less than 10%. This is attributable largely to the reduction in corporation tax from 28% to 26%.

 

Economic conditions remain difficult and there is the possibility that they may get worse. Against this background I consider the company's performance to be robust. The company has made significant purchases during these six months and in so doing has broadened the geographical base of its portfolio whilst not missing the opportunity to buy properties in prime London locations.

 

By making these purchases at this time the company has used its resources wisely when the market was at a low point. Although the economy may yet worsen these properties will show good appreciation and good profits when the market improves. As a result of these asset purchases, borrowings increased by approximately £30 million during the period. Nonetheless, the company continues to be very sound financially and is very well placed to make further good purchases when the opportunities can be found. 

 

I believe that with the right purchases and the right staff recruitment the company can contemplate the future with equanimity although with the current economic situation the next few years may prove challenging. Nevertheless I am confident that the company can weather any economic storms and come through them even more strongly placed. 

 

The interim dividend is maintained at 50 pence per share and will be payable on 26 March 2012 to shareholders on the register at 24 February 2012.

 

 

 

GROUP STATEMENT OF COMPREHENSIVE INCOME (UNAUDITED)

 

 

Half year ended 30.09.2011

£000

Half year

ended

30.09.2010

£000

Year

ended 31.03.2011

£000

Revenue

21,249

24,265

47,655

Cost of Sales

(8,239)

(9,091)

(18,548)

Gross Profit

13,010

15,174

29,107

Administrative expenses

Gain on disposal of investment properties

(1,588)

211

(1,832)

50

(4,454)

149

Operating profit before changes in

fair value of investment properties

11,633

13,392

24,802

Increase in fair value of investments

-

-

2,454

 

 

Profit from operations

11,633

13,392

27,256

 

Change in fair value of derivatives

-

-

(292)

Net finance costs

(1,885)

(1,751)

(3,404)

Profit before taxation

9,748

11,641

23,560

 

Taxation - current

(3,332)

(3,604)

(7,425)

Taxation - deferred

1,239

443

836

 

Taxation

(2,093)

(3,161)

(6,589)

 

Profit attributable to equity shareholders

7,655

8,480

16,971

 

Basic and diluted earnings per share (pence)

196.3

217.5p

435.3

 

 

 

All items within the consolidated income statement relate to continuing operations.

 

 

GROUP STATEMENT OF FINANCIAL POSITION (UNAUDITED)

 

As at

As at

As at

30.09.2011

30.09.2010

31.03.2011

£000

£000

£000

Assets

Non-current assets

Property plant and equipment

2,388

2,453

2,461

Investment properties

27,196

32,348

30,314

29,584

34,801

32,775

Current assets

Inventories of trading properties

295,976

252,966

259,462

Trade and other receivables

1,368

1,738

1,192

Cash and cash equivalents

175

115

116

297,519

254,819

260,770

 

Total assets

327,103

289,620

293,545

 

Equity and liabilities

 

Capital and reserves attributable

to equity holders of the company

 

Share capital

195

195

195

Capital redemption reserve

55

55

55

Capital reserve

25

25

25

Other reserve

56

56

56

Cash flow hedge reserve

(2,340)

(3,640)

(2,340)

Retained earnings

220,077

210,363

216,905

 

 

218,068

207,054

214,896

Non-current liabilities

Long-term borrowings

80,000

55,000

50,000

Deferred tax

6,082

7,713

7,321

86,082

62,713

57,321

Current liabilities

Bank overdrafts and loans

16,233

11,768

13,940

Trade and other payables

743

920

1,485

Current tax payable

3,345

3,525

3,271

Derivative financial instruments

2,632

3,640

2,632

 

22,953

19,853

21,328

 

Total liabilities

109,035

82,566

78,649

 

Total equity and liabilities

327,103

289,620

293,545

 

 

GROUP CASHFLOW STATEMENT (UNAUDITED)

 

 

Half year

Half year

Year

ended

ended

ended

30.09.2011

30.09.2010

31.03.2011

£000

£000

£000

Cash flows from operating activities

Profit from operations

11,633

13,392

27,256

Adjustment for:

Depreciation

70

75

174

Loss/(Gain) on disposal of property, plant and equipment

3

(17)

11

Gain on disposal of investment properties

(211)

-

-

(Increase) in fair value of investment properties

-

-

(2,454)

Cash flow from operations before movement

in working capital

11,495

13,450

24,987

(Increase)/Decrease in inventories

(36,514)

3,999

(2,498)

(Increase)/Decrease in receivables

(176)

(541)

5

(Decrease)/Increase in payables

(740)

(488)

125

Cash generated from operations

(25,935)

16,420

22,619

 

Interest paid

(1,885)

(1,751)

(3,404)

Income taxes paid

(3,261)

(3,891)

(8,027)

Net cash (outflow)/ inflow from operating activities

 

(31,081)

 

10,778

 

11,188

 

Investing activities

Proceeds from disposal of investment properties

4,029

1,100

6,600

Proceeds from disposal of property, plant and equipment

Purchase of property, plant and equipment

4

(3)

39

(129)

-

(309)

Capital expenditure on investment properties

(700)

(525)

(1,438)

Net cash inflow from investing activities

3,330

485

4,853

 

Cash flows from financing activities

 

Increase in borrowings

29,800

-

-

Repayment of borrowings

-

(9,800)

(14,700)

Equity dividend paid

(4,483)

(4,483)

(6,432)

Net cash inflow/(outflow) from financing activities

25,317

(14,283)

(21,132)

 

Net (decrease) in cash and cash equivalents

(2,434)

(3,020)

(5,091)

 

Opening cash and cash equivalents

(13,349)

(8,258)

(8,258)

Closing cash and cash equivalents

(15,783)

(11,278)

(13,349)

 

 

GROUP CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

 

 

 

 

Half year

Half year

Year

ended

ended

ended

30.09.2011

30.09.2010

31.03.2011

£000

£000

£000

Shareholders' funds as at the beginning of the period

 

214,896

 

203,057

 

203,057

Reduction in reserve

-

-

1,300

 

Profit for the period

7,655

8,480

16,971

Dividends

(4,483)

(4,483)

(6,432)

Shareholders' funds at the end of the period

218,068

207,054

214,896

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR FDDFSSFFSEEF
Date   Source Headline
26th May 202610:27 amRNSUpdate on General Meeting voting outcome
20th Apr 202611:00 amRNSHolding(s) in Company
20th Apr 202610:59 amRNSHolding(s) in Company
20th Apr 202610:58 amRNSHolding(s) in Company
31st Mar 202611:05 amRNSDirector/PDMR Shareholding
30th Mar 20266:30 pmRNSDividend Payment Delay
25th Mar 20265:04 pmRNSDirector/PDMR Shareholding
25th Mar 202610:01 amRNSDirector/PDMR Shareholding
19th Mar 202610:02 amRNSDirector/PDMR Shareholding
18th Mar 202612:29 pmRNSDirector/PDMR Shareholding
25th Feb 20264:21 pmRNSDirector/PDMR Shareholding
23rd Feb 202612:49 pmRNSDirector/PDMR Shareholding
12th Feb 202612:03 pmRNSDirector/PDMR Shareholding
10th Feb 20264:28 pmRNSDirector/PDMR Shareholding
9th Feb 202611:16 amRNSDirector/PDMR Shareholding
26th Jan 20263:38 pmRNSBoard Committee change
22nd Dec 202511:40 amRNSDirector/PDMR Shareholding
22nd Dec 202511:40 amRNSDirector/PDMR Shareholding
20th Nov 20257:00 amRNSUnaudited Interim Results for 6m ended 30 Sep 2025
17th Nov 202512:15 pmRNSResult of General Meeting
22nd Oct 202512:00 pmRNSNotice of General Meeting
17th Oct 202512:22 pmRNSDirector/PDMR Shareholding
16th Oct 20251:04 pmRNSDirector/PDMR Shareholding
15th Oct 20254:29 pmRNSDirector/PDMR Shareholding
1st Oct 20251:16 pmRNSDirector/PDMR Shareholding
15th Aug 20257:03 amRNSBoard changes
13th Aug 20251:46 pmRNSResult of Annual General Meeting
30th Jul 20255:10 pmRNS2025 Annual Report and Accounts
24th Jul 202512:32 pmRNSDirector/PDMR Shareholding
22nd Jul 20251:05 pmRNSDirector/PDMR Shareholding
17th Jul 20255:20 pmRNSDirector/PDMR Shareholding
11th Jul 202511:22 amRNSPublication of 2025 Annual Report & Notice of AGM
19th Jun 20257:00 amRNSPreliminary Results: year ended 31 March 2025
16th May 20257:00 amRNSUpdate on General Meeting voting outcome
31st Mar 20257:00 amRNSDirectorate change – Contract Extension
26th Mar 202512:02 pmRNSDirector/PDMR Shareholdings
28th Feb 20255:25 pmRNSDirector/PDMR Shareholding
14th Feb 20257:00 amRNSUpdate on 2024 Annual General Meeting outcome
21st Nov 20242:09 pmRNSDirector/PDMR Shareholding
20th Nov 20247:00 amRNSUnaudited Interim Results for 6m ended 30 Sep 2024
19th Nov 20249:59 amRNSDirectorate Change
18th Nov 202412:07 pmRNSResult of General Meeting
23rd Oct 202412:00 pmRNSNotice of General Meeting
19th Sep 20246:11 pmRNSDirector/PDMR Shareholding
14th Aug 20241:37 pmRNSResult of Annual General Meeting
23rd Jul 20248:58 amRNSPublication of 2024 Annual Report and Accounts
12th Jul 20249:31 amRNSAnnual Financial Report and Notice of AGM
20th Jun 20247:00 amRNSPreliminary Results: year ended 31 March 2024
20th May 20247:00 amRNSUpdate on General Meeting voting outcome
14th Mar 20242:04 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.